Jonathan Pan, Ph.D, Mba Email & Phone Number

United States

Cambridge, MA, US

Brentford, Middlesex, GB

 Leading an organization of 250+ people and >$120M+ turnover in Malaysia and Brunei, rebuilding the business in 2021 to exceed pre-pandemic 2019 levels with headcount expansion, new offices and achieving double digit growth in 2022 Led business units to deliver market share gains in all promoted General Medicines and secured top Market Share position for.

Brentford, Middlesex, GB

 Led the formation of the medicine commercialization team, and enabling critical Commit to File and Launch decision with members of GSK Commercial Leadership Team (GCLT), enabling simultaneous approval and launch in the US and Europe in less than 2 years Set pricing strategy for BLENREP and developed framework to enable patient access while also.

Kuala Lumpur, Wilayah Persekutuan, MY

Kuala Lumpur, Wilayah Persekutuan, MY

Petaling Jaya, Selangor, MY

Petaling Jaya, Selangor, MY

 Led full development team including commercial, CMC, regulatory affairs, medical affairs, clinical operations and translation medicine for two development assets in immunology therapy areas Managed relationship with Kyowa Hakko Kirin for Anti-LIGHT program in Crohn’s Disease and second asset in another rare and orphan disease indication Initiated and.

 Leading team of scientists and clinical operations staff in the development and execution of a comprehensive biomarker and companion diagnostic strategy from translational research, development, and regulatory through to commercialization Led regulatory Pre-Sub with FDA and met with Division Director, Deputy Director and Branch Chief, among others, to.

Lawrence Township, NJ, US

 Leading cross-tumor, cross-geography commercial strategy development across 5 different priority markets and >30 tumor types, integrating into one cohesive go-to market strategy for Opdivo, Yervoy, Empliciti and other oncology assets Developed long-term risk mitigation strategy and developed tactical implementation to build strategic capabilities.

New Brunswick, NJ, US

 Led and built the comprehensive commercial function including: new product strategy, global marketing, local marketing, business insights and overall commercial strategy with a team of 10 direct reports, managing a >$250MM P&L with >$25MM in brand marketing and G&A expenses; matrix leadership with regulatory, supply chain, sales and R&D Launched new.

Basel, Baselstadt, CH

Brentford, Middlesex, GB

Reporting to the Global Head of Commercial at GSK Oncology and Medicine Commercialization Leader for Tafinlar and Mekinist, responsible for the commercial planning of companion diagnostics for pipeline products, go-to market strategy formulation and deployment for launched products (e.g., BRAF, MEK) and the formation of GSK’s enterprise diagnostic.

Cambridge, MA, US

Cambridge, MA, US

Scientia Advisors is a global consulting firm focused on helping senior executives in the healthcare and life science industries select the right markets, choose attractive product opportunities, and streamline operations. Our clients range from Global 50 companies to emerging firms with cutting-edge technologies in healthcare, biotechnology, devices.

Danbury, CT, US

Served as a managing consultant on a long-standing, large oncology engagement, which has stemmed multiple follow-on projects Served as project manager for a global aesthetic market analysis project, liaising between 4 different global geographies, positioning our client to respond to market changes Managed and led development of market intelligence in.

Worldwide, OO

 Actively participated in major engagements focused on mitigating risk exposure and compliance for Federal clients Supported solution development in the healthcare segment to develop a logical database for electronic health records and partitioning data based upon use and need, while also remaining HIPAA compliant Developed and implemented project plans.

Ann Arbor, Michigan, US

Ann Arbor, Michigan, US

Bristow, VA, US

 Actively participated on private equity engagements focused on the middle markets, detailing market dynamics, customer segments, and consumer/ competitive landscapes; playing a key role in reworking investment dynamics that totaled to approximately $200 million  Studied and identified market dynamics and trends of this particular market niche; utilized.

Ph.D, Cellular And Molecular Biology

Master Of Science - Ms, Biology

B.Sc, Cellular And Molecular Biology

Finance And Operations

Mba, Business Administration - Strategy And Finance

Biology